JAPANESE
About us
Our business
Our business
Pharmaceutical wholesaling
Customer support system
Logistics system
Dispensing pharmacy
Pharmaceutical manufacturing and sales
SMO
Others
News releases
Investor relations
IR information
Management policy
Financial data
IR filing
Stock information
Medium-term management plan
IR calendar
Risk information
Electronic public notice
Contact information for IR
Disclaimer
Corporate information
Corporate information
Company overview
Top message
Vision statement
History
Organization
Executives
Kyoso Mirai Group companies
Company profile data
Sustainability
Sustainability TOP
Sustainability
Message
Materiality
Code of conduct
Value creation story
Environment
Social
Governance
Procurement
Report / ESG date
Policies
Contact us
JAPANESE
Home
News releases
2021
News releases
2021
Feb 15, 2021
product/service
product/service
Notice Regarding Marketing Approvals for 2 Ingredients / 5 Products of Generic Drugs for KYOSOMIRAI PHARMA(164 KB)
Feb 09, 2021
performance
performance
Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2021(321 KB)
Jan 18, 2021
product/service
product/service
Announcement of Release of the Online Medical Examination / Dosing Guidance System named “KAITOS”(176 KB)
Jan 15, 2021
M&A/partnership
M&A/partnership
Announcement of Capital and Business Alliance with KUBIX Inc.(70 KB)
Prev
1
2
3
